Quest Diagnostics (DGX) Tops Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts DGX Hot Sheet
Price: $235.50 -0.69%
EPS Growth %: +10.0%
Financial Fact:
Dividends per common share: 0.4
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +10.0%
Financial Fact:
Dividends per common share: 0.4
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Quest Diagnostics (NYSE: DGX) reported Q3 EPS of $1.28, $0.02 better than the analyst estimate of $1.26. Revenue for the quarter came in at $1.88 billion versus the consensus estimate of $1.89 billion.
Quest Diagnostics sees FY2015 EPS of $4.75-$4.80, versus the consensus of $4.76.
For earnings history and earnings-related data on Quest Diagnostics (DGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Quest Diagnostics (DGX) PT Raised to $245 at UBS
- BMO Capital Starts Carter's (CRI) at Outperform
- Braze stock tumbles 10% on weak third quarter EPS guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
